Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes

Journal of Endocrinological Investigation

Volumn 39, Issue 12, 2016, Pages 1425-1434

  Talaat, I M ^a   Nasr, A ^b,c   Alsulaimani, A A ^d   Alghamdi, H ^e   Alswat, K A ^d   Almalki, D M ^e   Abushouk, A ^b   Saleh, A M ^f   Allam, G ^d,g  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Division of Physiology   (Saudi Arabia)

^c AL NEELAIN UNIVERSITY   (Sudan)

^d TAIF UNIVERSITY   (Saudi Arabia)

^e Prince Mansour Military Community Hospital ^*  (Saudi Arabia)

^f Faculty of Applied Medical Sciences   (Saudi Arabia)

^g Beni Suef University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; TUMOR NECROSIS FACTOR; 25-HYDROXYVITAMIN D; VITAMIN D;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BODY MASS; BONE MINERAL; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MINERAL METABOLISM; PANCREAS ISLET CELL; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PATHOPHYSIOLOGY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; MALE;

AUTOANTIBODIES; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOMODULATION; MALE; VITAMIN D;

EID: 84994890744     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0514-9     Document Type: Article

References (44)

1. Nielsen K, Karlsen AE, Deckert M, Madsen OD, Serup P, Mandrup-Poulsen T, Nerup J (1999) Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 48(12):2324–2332
2. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39(9):1005–1029
3. Zella JB, DeLuca HF (2003) Vitamin D and autoimmune diabetes. J Cell Biochem 88(2):216–222
4. Gysemans C, Callewaert H, Overbergh L, Mathieu C (2008) Cytokine signalling in the beta-cell: a dual role for IFN gamma. Biochem Soc Trans 36(Pt 3):328–333
5. Haller MJ, Schatz DA (2008) Cytokines and type 1 diabetes complications: casual or causal association? Pediatr Diabetes 9(1):1–2
6. Rabinovitch A, Suarez-Pinzon WL (2007) Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem Biophys 48(2–3):159–163
7. Tilg H, Moschen AR (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14(3–4):222–231
8. Cantorna MT, Humpal-Winter J, DeLuca HF (2000) In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch Biochem Biophys 377(1):135–138
9. Turer CB, Lin H, Flores G (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131(1):e152–e161
10. Dong Y, Stallmann-Jorgensen IS, Pollock NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas J, Pierce GL, White J, Holick MF, Zhu H (2010) A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab 95(10):4584–4591
11. Adams S, Brown H, Turner G (2002) Breaking down the blood-brain barrier: signaling a path to cerebral malaria? Trends Parasitol 18(8):360–366
12. Dusso A, Brown A, Slatopolsky E (1994) Extrarenal production of calcitriol. Semin Nephrol 14(2):144–155
13. Dusso AS, Kamimura S, Gallieni M, Zhong M, Negrea L, Shapiro S, Slatopolsky E (1997) Gamma-interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: a mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82(7):2222–2232
14. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358(9292):1500–1503
15. Stene LC, Joner G (2003) Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 78(6):1128–1134
16. Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26–34
17. Krampl E, Lees C, Bland JM, Espinoza Dorado J, Moscoso G, Campbell S (2000) Fetal biometry at 4300 m compared to sea level in Peru. Ultrasound Obstet Gynecol 16(1):9–18
18. Pritsch O, Hudry-Clergeon G, Buckle M, Petillot Y, Bouvet JP, Gagnon J, Dighiero G (1996) Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies? J Clin Invest 98(10):2235–2243
19. Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG (2008) Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med 40(2):82–91
20. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930
21. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL (2012) IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97(4):1146–1152
22. Cook EB, Stahl JL, Lowe L, Chen R, Morgan E, Wilson J, Varro R, Chan A, Graziano FM, Barney NP (2001) Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods 254(1–2):109–118
23. Khothari CR (2004) Research methodology: methods and techniques. New Age International, New Delhi
24. Feng R, Li Y, Li G, Li Z, Zhang Y, Li Q, Sun C (2015) Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract 108(3):e71–e75
25. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C (2011) Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 347(1–2):106–120
26. Fassbender WJ, Goertz B, Weismuller K, Steinhauer B, Stracke H, Auch D, Linn T, Bretzel RG (2002) VDR gene polymorphisms are overrepresented in german patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res 34(6):330–337
27. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31–38
28. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124(3):e362–e370
29. Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48(7):1247–1257
30. Mohr S, Garland C, Gorham E, Garland F (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51(8):1391–1398
31. Östman J, Lönnberg G, Arnqvist H, Blohme G, Bolinder J, Schnell AE, Eriksson J, Gudbjörnsdottir S, Sundkvist G, Nyström L (2008) Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983–2002. J Intern Med 263(4):386–394
32. Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez Kitchen CM, Funderburg N, Mesiano S, Bernstein HB (2012) Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol 188(12):6338–6346
33. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR Jr, He K (2010) Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care 33(12):2604–2610
34. Sales CH, Pedrosa Lde F (2006) Magnesium and diabetes mellitus: their relation. Clin Nutr 25(4):554–562
35. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, Weiss GE, Molina DM, Burk CR, Waisberg M, Jasinskas A, Tan X, Doumbo S, Doumtabe D, Kone Y, Narum DL, Liang X, Doumbo OK, Miller LH, Doolan DL, Baldi P, Felgner PL, Pierce SK (2010) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci USA 107:6958–6963
36. Takaya J, Higashino H, Kobayashi Y (2004) Intracellular magnesium and insulin resistance. Magnes Res 17(2):126–136
37. Kelishadi R, Ataei E, Ardalan G, Nazemian M, Tajadini M, Heshmat R, Keikha M, Motlagh ME (2014) Relationship of serum magnesium and vitamin D Levels in a nationally-representative sample of Iranian adolescents: The CASPIAN-III Study. Int J Prev Med 5(1):99–103
38. Munger KL, Levin LI, Massa J, Horst R, Orban T, Ascherio A (2013) Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. Am J Epidemiol 177(5):411–419
39. Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes 41(11):1491–1495
40. Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89(5):922–932
41. Bemiss CJ, Mahon BD, Henry A, Weaver V, Cantorna MT (2002) Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch Biochem Biophys 402(2):249–254
42. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17(12):2386–2392
43. Lemire JM (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 53(1–6):599–602
44. Franco MM, Moraes MMM, Duarte PM, Napimoga MH, Benatti BB (2015) Glycemic control and the production of cytokines in diabetic patients with chronic periodontal disease. RGO-Revista Gaúcha de Odontologia 63(4):432–438